In Treatment of Parkinson's disease Tidomet Plus Tablet is one of the most effective medications to relieve symptoms of Parkinson's disease such as tremors, muscle stiffness, and difficulty moving. It increases the amount of a chemical called dopamine in the brain which helps in the coordination of body movements. This medicine can therefore enhance the quality of life by improving the ability to carry out daily functions in a better manner.
It is unsafe to consume alcohol with Tidomet Plus Tablet.
Tidomet Plus Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Tidomet Plus Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby. Partial to complete suppression of lactation was seen in mothers on the treatment with Tidomet Plus Tablet, but when the treatment was stopped, lactation returned to normal levels.
Tidomet Plus Tablet may cause side effects which could affect your ability to drive. As Tidomet Plus Tablet may cause dizziness, drowsiness, double vision, which may affect your ability to react which may affect your ability to drive.
Tidomet Plus Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Tidomet Plus Tablet may not be needed in these patients. Please consult your doctor.
Tidomet Plus Tablet should be used with caution in patients with liver disease. Dose adjustment of Tidomet Plus Tablet may be needed. Please consult your doctor.
If you miss a dose of Tidomet Plus Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Intas Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Micro Labs Ltd || ₹14.5/tablet (25% cheaper)